Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy

Overview of attention for article published in Drug Design, Development and Therapy, June 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 2 X users

googleplus: 1 Google+ user

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Dove Medical Press (NZ) Ltd, 24 Jun 2015

Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased... Combination of…